Thanks to a new Food and Drug Administration (FDA) approval, an innovative new treatment approach is now available to significantly more men with advanced prostate cancer. The administration expanded ...

Off-label means that a doctor prescribes a medication for a reason or at a dose that the Food and Drug Administration (FDA) has not approved. Learn more about how to get Zepbound from LillyDirect ...

They secured what they needed to protect themselves and their belongings from corrosive ashfall, which can irritate eyes and lungs: KN95 masks, window-sealing tape and vehicle air filters. But first, ...

Food and Drug Administration leaders directly intervened to halt approval of a Covid-19 vaccine ... Several officials characterized FDA Commissioner Marty Makary, who signed off on the ouster ...

TOKYO: Bank of Japan Governor Kazuo Ueda said on Wednesday (Apr 9) the central bank will carefully analyse how US tariffs could affect the economy in making monetary policy decisions. "Domestic ...

The US Food and Drug Administration (FDA) has approved inebilizumab-cdon (Uplizna ®) for the treatment of adults with immunoglobulin G4-related disease (IgG4-RD). This is a major milestone, marking ...

Orthocell says FDA approval for its Remplir nerve regeneration conduit was timely in more ways than one The approval leverages the $80 million Orthocell spent to develop its collagen-based Celgro ...

Luckily, Amazon has slashed the cost of a sleep mask with built-in headphones - it’s 50% cheaper and travellers love it. LG-Dolida Bluetooth Sleep Mask, £34.99 (was £69.99) Holiday season isn ...

The company has also filed for FDA approval of its flu+Covid combination vaccine, mRNA-1083. If approved, it will be the first in the US to offer protection against flu and Covid-19 in a single shot.

The accelerated approval for nivolumab monotherapy in unresectable/metastatic MSI-H/dMMR CRC has also been converted to regular approval. The FDA has approved the use ...

Ziftomenib’s FDA application for relapsed/refractory NPM1-mutant acute myeloid leukemia is supported by data from the KOMET-001 trial. A new drug application (NDA) seeking the approval of ziftomenib ...